Precision drug design against Acidovorax oryzae: leveraging bioinformatics to combat rice brown stripe disease

Bacterial brown stripe disease caused by Acidovorax oryzae is a major threat to crop yields, and the current reliance on pesticides for control is unsustainable due to environmental pollution and resistance. To address this, bacterial-based ligands have been explored as a potential treatment solution. In this study, we developed a protein–protein interaction (PPI) network for A. oryzae by utilizing shared differentially expressed genes (DEGs) and the STRING database. Using a maximal clique centrality (MCC) approach through CytoHubba and Network Analyzer, we identified hub genes within the PPI network. We then analyzed the genomic data of the top 10 proteins, and further narrowed them down to 2 proteins by utilizing betweenness, closeness, degree, and eigenvector studies. Finally, we used molecular docking to screen 100 compounds against the final two proteins (guaA and metG), and Enfumafungin was selected as a potential treatment for bacterial resistance caused by A. oryzae based on their binding affinity and interaction energy. Our approach demonstrates the potential of utilizing bioinformatics and molecular docking to identify novel drug candidates for precision treatment of bacterial brown stripe disease caused by A. oryzae, paving the way for more targeted and sustainable control strategies. The efficacy of Enfumafungin in inhibiting the growth of A. oryzae strain RS-1 was investigated through both computational and wet lab methods. The models of the protein were built using the Swiss model, and their accuracy was confirmed via a Ramachandran plot. Additionally, Enfumafungin demonstrated potent inhibitory action against the bacterial strain, with an MIC of 100 µg/mL, reducing OD600 values by up to 91%. The effectiveness of Enfumafungin was further evidenced through agar well diffusion assays, which exhibited the highest zone of inhibition at 1.42 cm when the concentration of Enfumafungin was at 100 µg/mL. Moreover, Enfumafungin was also able to effectively reduce the biofilm of A. oryzae RS-1 in a concentration-dependent manner. The swarming motility of A. oryzae RS-1 was also found to be significantly inhibited by Enfumafungin. Further validation through TEM observation revealed that bacterial cells exposed to Enfumafungin displayed mostly red fluorescence, indicating destruction of the bacterial cell membrane.

[1]  Yue Ma,et al.  Drug repurposing strategy II: from approved drugs to agri-fungicide leads , 2023, The Journal of Antibiotics.

[2]  Ayaz Ahmad,et al.  Identification of small inhibitors for human Metadherin, an oncoprotein, through Insilco approach. , 2023, Current computer-aided drug design.

[3]  Nadezhda T. Doncheva,et al.  Correction to ‘The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets’ , 2021, Nucleic acids research.

[4]  Sanghyun Park,et al.  Binding affinity prediction for protein–ligand complex using deep attention mechanism based on intermolecular interactions , 2021, BMC Bioinformatics.

[5]  Shyi-Long Lee,et al.  Atomistic simulation on flavonoids derivatives as potential inhibitors of bacterial gyrase of Staphylococcus aureus , 2020, Journal of biomolecular structure & dynamics.

[6]  A. Maritan,et al.  True scale-free networks hidden by finite size effects , 2020, Proceedings of the National Academy of Sciences.

[7]  J. Jeyakanthan,et al.  Molecular docking, dynamics and free energy analyses of Acinetobacter baumannii OXA class enzymes with carbapenems investigating their hydrolytic mechanisms. , 2020, Journal of medical microbiology.

[8]  P. Adams,et al.  A global Ramachandran score identifies protein structures with unlikely stereochemistry , 2020, bioRxiv.

[9]  Yanli Wang,et al.  Biosynthesis of silver nanoparticle from pomelo (Citrus Maxima) and their antibacterial activity against acidovorax oryzae RS-2 , 2020, Materials Research Express.

[10]  Gang Wu,et al.  Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis , 2019, Cancer management and research.

[11]  Bin Li,et al.  Biogenic Synthesis of Silver Nanoparticles Using Phyllanthus emblica Fruit Extract and Its Inhibitory Action Against the Pathogen Acidovorax oryzae Strain RS-2 of Rice Bacterial Brown Stripe , 2019, Front. Microbiol..

[12]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[13]  M. Hossain,et al.  Halotolerant bacteria belonging to operational group Bacillus amyloliquefaciens in biocontrol of the rice brown stripe pathogen Acidovorax oryzae , 2018, Journal of applied microbiology.

[14]  A. Poso,et al.  Binding Affinity via Docking: Fact and Fiction , 2018, Molecules.

[15]  Jason E Gestwicki,et al.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. , 2018, Current opinion in chemical biology.

[16]  J. Asante,et al.  Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics. , 2018, Future microbiology.

[17]  Gnanendra Shanmugam,et al.  Computer-Aided Drug Discovery in Plant Pathology , 2017, The plant pathology journal.

[18]  Ola Engkvist,et al.  On the Integration of In Silico Drug Design Methods for Drug Repurposing , 2017, Front. Pharmacol..

[19]  Frances M. G. Pearl,et al.  Bioinformatics in translational drug discovery , 2017, Bioscience reports.

[20]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[21]  B. Li,et al.  Inhibitory Effect of Camptothecin against Rice Bacterial Brown Stripe Pathogen Acidovorax avenae subsp. avenae RS-2 , 2016, Molecules.

[22]  Theodora Katsila,et al.  Computational approaches in target identification and drug discovery , 2016, Computational and structural biotechnology journal.

[23]  Chandrajit Lahiri,et al.  Computational analysis of protein interaction networks for infectious diseases , 2015, Briefings Bioinform..

[24]  K. Kantardjieff,et al.  Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D β-Lactamases. , 2015, ACS chemical biology.

[25]  Essam K. F. Elbeshehy,et al.  Silver nanoparticles synthesis mediated by new isolates of Bacillus spp., nanoparticle characterization and their activity against Bean Yellow Mosaic Virus and human pathogens , 2015, Front. Microbiol..

[26]  Xing-Ming Zhao,et al.  A Survey on the Computational Approaches to Identify Drug Targets in the Postgenomic Era , 2015, BioMed research international.

[27]  R. García-Contreras,et al.  Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections , 2015, Front. Microbiol..

[28]  Yanli Wang,et al.  Membrane protein profiling of Acidovorax avenae subsp. avenae under various growth conditions , 2015, Archives of Microbiology.

[29]  Md. Ismail Hosen,et al.  Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11 , 2014, Interdisciplinary Sciences: Computational Life Sciences.

[30]  H. Wertheim,et al.  Antibiotic resistance-the need for global solutions. , 2013, The Lancet. Infectious diseases.

[31]  S. Shakil,et al.  A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians , 2013, EXCLI journal.

[32]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[33]  Joris Hulstijn,et al.  Control Automation to Reduce Costs of Control , 2012, Int. J. Inf. Syst. Model. Des..

[34]  Jeffrey Aubé,et al.  Drug repurposing and the medicinal chemist. , 2012, ACS medicinal chemistry letters.

[35]  G. Xie,et al.  Genome Sequence of the Rice-Pathogenic Bacterium Acidovorax avenae subsp. avenae RS-1 , 2011, Journal of bacteriology.

[36]  R. Bonomo,et al.  Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem. , 2011, Journal of molecular biology.

[37]  B. Maigret,et al.  Comparative genomics allowed the identification of drug targets against human fungal pathogens , 2011, BMC Genomics.

[38]  H. Sheikh,et al.  Antimicrobial activity of certain bacteria and fungi isolated from soil mixed with human saliva against pathogenic microbes causing dermatological diseases , 2010, Saudi journal of biological sciences.

[39]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[40]  R. Sanchez,et al.  Improving accuracy and efficiency of blind protein‐ligand docking by focusing on predicted binding sites , 2009, Proteins.

[41]  Cleidson Valgas,et al.  Screening methods to determine antibacterial activity of natural products , 2007 .

[42]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[43]  W. Song,et al.  Detection of Acidovorax avenae ssp. avenae in Rice Seeds Using BIO-PCR , 2004 .

[44]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[45]  R. Schwartz,et al.  The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms. , 2000, Systematic and applied microbiology.

[46]  R. Schwartz,et al.  Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors , 2000, Antimicrobial Agents and Chemotherapy.

[47]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[48]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[49]  George J. Stigler,et al.  The Economies of Scale , 1958, The Journal of Law and Economics.

[50]  T. Schwede,et al.  Protein structure homology modeling using SWISS-MODEL workspace , 2008, Nature Protocols.

[51]  S Magaldi,et al.  Well diffusion for antifungal susceptibility testing. , 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.